Kyverna Therapeutics logo

Kyverna Therapeutics Share Price (NASDAQ: KYTX)

$3.71

0.01

(0.27%)

Last updated on

Check the interactive Kyverna Therapeutics Stock chart to analyse performance

Kyverna Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.71
    Today's High:$4.03

    Day's Volatility :7.94%

  • 52 Weeks Low:$1.78
    52 Weeks High:$8.28

    52 Weeks Volatility :78.5%

Kyverna Therapeutics Stock Returns

PeriodKyverna TherapeuticsIndex (Russel 2000)
3 Months
40.0%
0.0%
6 Months
43.24%
0.0%
1 Year
-49.56%
0.0%
3 Years
-87.63%
-4.7%

Kyverna Therapeutics Key Stats

Check Kyverna Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.7
Open
$3.83
Today's High
$4.03
Today's Low
$3.71
Market Capitalization
$160.0M
Today's Volume
$322.8K
52 Week High
$8.28
52 Week Low
$1.78
Revenue TTM
$0.0
EBITDA
$-170.4M
Earnings Per Share (EPS)
$-3.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-49.72%

Stock Returns calculator for Kyverna Therapeutics Stock including INR - Dollar returns

The Kyverna Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kyverna Therapeutics investment value today

Current value as on today

₹55,692

Returns

₹44,308

(-44.31%)

Returns from Kyverna Therapeutics Stock

₹49,592 (-49.59%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Kyverna Therapeutics Stock

27%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Kyverna Therapeutics Stock from India on INDmoney has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Kyverna Therapeutics Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Kyverna Therapeutics(by analysts ranked 0 to 5 stars)

Kyverna Therapeutics Share Price Target

What analysts predicted

Upside of 363.61%

Target:

$17.20

Current:

$3.71

Kyverna Therapeutics share price target is $17.20, a slight Upside of 363.61% compared to current price of $3.71 as per analysts' prediction.

Kyverna Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, KYTX stock has moved down by -3.6%
  • KYTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 123.7%

Kyverna Therapeutics Technicals Summary

Sell

Neutral

Buy

Kyverna Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Kyverna Therapeutics Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kyverna Therapeutics logo
3.92%
43.24%
-49.56%
-87.63%
-87.63%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Kyverna Therapeutics

Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. The company's lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome and myasthenia gravis that is in phase 2 clinical trial; and for lupus nephritis. It is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing, as well as KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Organization
Kyverna Therapeutics
Employees
129
CEO
Mr. Warner Biddle
Industry
Miscellaneous

Key Management of Kyverna Therapeutics

NameTitle
Mr. Warner Biddle
CEO & Director
Ms. Karen Walker
Chief Technology Officer
Dr. Marc Grasso M.D.
Chief Financial Officer
Dr. Tom Van Blarcom Ph.D.
Senior VP & Head of Research
Ms. Tracy Rossin
Senior Vice President of Corporate Affairs & Communications and Investor Relations
Ms. Cara Bauer Ph.D.
Chief Human Resources Officer
Mr. Dan Maziasz
Chief Business Officer
Dr. Naji H. Gehchan M.B.A., M.D.
Chief Medical & Development Officer
Dr. Sham Dholakia DPHIL, M.D.
Chief Product Officer

Important FAQs about investing in KYTX Stock from India :

What is Kyverna Therapeutics share price today?

Kyverna Therapeutics share price today is $3.71 as on at the close of the market. Kyverna Therapeutics share today touched a day high of $4.03 and a low of $3.71.

What is the 52 week high and 52 week low for Kyverna Therapeutics share?

Kyverna Therapeutics share touched a 52 week high of $8.28 and a 52 week low of $1.78. Kyverna Therapeutics stock price today i.e. is closed at $3.71, lower by 55.19% versus the 52 week high.

How to invest in Kyverna Therapeutics Stock (KYTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kyverna Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kyverna Therapeutics Shares that will get you 0.4043 shares as per Kyverna Therapeutics share price of $3.71 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Kyverna Therapeutics Stock (KYTX) from India?

Indian investors can start investing in Kyverna Therapeutics (KYTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Kyverna Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Kyverna Therapeutics share’s latest price of $3.71 as on August 30, 2025 at 1:29 am IST, you will get 2.6954 shares of Kyverna Therapeutics. Learn more about fractional shares .

What are the returns that Kyverna Therapeutics has given to Indian investors in the last 5 years?

Kyverna Therapeutics stock has given -87.63% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?